“It seems to be possible that we could have efficacy data by, let’s say, Thanksgiving,” Moderna (ticker: MRNA) CEO Stéphane Bancel said during conference Wednesday. That data would potentially allow Moderna to fight for approval either late this year or early in the new year, Bancel said. Barron's
Thursday, June 18, 2020
Moderna’s Coronavirus Vaccine Will Be Ready for Distribution in 2021, CEO Says
“It seems to be possible that we could have efficacy data by, let’s say, Thanksgiving,” Moderna (ticker: MRNA) CEO Stéphane Bancel said during conference Wednesday. That data would potentially allow Moderna to fight for approval either late this year or early in the new year, Bancel said. Barron's
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment